Biological Safety Testing Products & Services Market To Reach $12.09 Billion By 2033

Biological Safety Testing Products And Services Market Growth & Trends

The global biological safety testing products & services market size is estimated to reach USD 12.09 billion by 2033, registering a CAGR of 10.69% from 2026 to 2033, according to a new report by Grand View Research, Inc. The market is predominantly driven by the increasing production of biologics, boosting the demand for highly effective biological safety testing tools. The increasing disease burden is expected to be a major factor responsible for the rising production of biologics, thereby propelling the market growth.

The increasing prevalence of chronic diseases associated with lifestyle, including diabetes and cancer, is a key factor contributing to the rise in drug development and subsequent commercialization. This is expected to increase the need for ensuring & scrutinizing the safety of specialized and targeted therapies, evaluating outcomes, and circumventing probable shortcomings. In addition, biotechnology and pharmaceutical companies are increasingly integrating biological safety testing products and services to produce contamination-free and highly potent biologics to cater to the large number of people suffering from target diseases. Safety testing for viral conditions is proving to be one of the primary concerns of most companies as it is a critical component of manufacturing, chemistry, and control of biologics. This is fueling growth opportunities in the market.

Laboratory-based contamination is leading to the development and refinement of workstations by incorporating biological safety products and services. The increasing need to work with tissue cultures, maintain the sterility of cell lines, and minimize cross-contamination has increased concerns regarding product integrity. Rising involvement by government healthcare organizations for implementing good manufacturing practices and subsequent testing & control at every production stage is expected to widen the scope for growth.

Furthermore, key players operating in the biological safety testing product & services market are constantly focusing on developing novel products and technologies, further expanding their product portfolio, and to meet the rising demand for biological safety testing globally. For instance, in December 2022, -Charles River Laboratories International, Inc. announced the launch of Endosafe Nexus 200, a fully robotic instrument capable of processing both complex or undiluted, serial dilutions for water, in-process, and final product testing, further expanding its endotoxin testing portfolio. The incorporation of automation through robotics has enabled streamlining the quality control process and subsequently improving overall process efficiency.

 Request a free sample copy or view report summary: Biological Safety Testing Products And Services Market Report

Biological Safety Testing Products And Services Market Report Highlights

• Based on product, the reagents and kits accounted for the largest market share of 39.38% in 2025.

• Based on application, the vaccine and therapeutics held the largest share, based on application, in 2025, of 24.37%, and is anticipated to grow at the fastest CAGR over the forecast period.

• On the basis of test, the endotoxin tests dominated the market in terms of revenue in 2025 with a market share of 21.33%.

• North America biological safety testing products & services market held the largest share of the global market in 2025, with a market share of 36.47%, attributed to substantial investments in biotechnology, growing adoption in cancer research, and the advancement of novel biologics, vaccines, and drugs.

Biological Safety Testing Products And Services Market Segmentation

Grand View Research has segmented the global biological safety testing products & services market based on product, application, test, and region:

Biological Safety Testing Products & Services Product Outlook (Revenue, USD Million, 2021 - 2033)

• Reagents & Kits

• Instruments

• Services

Biological Safety Testing Products & Services Application Outlook (Revenue, USD Million, 2021 - 2033)

• Vaccines & Therapeutics

  • Vaccines

  • Monoclonal Antibodies

  • Recombinant Protein

• Blood & Blood-based Products

• Gene Therapy

• Tissue & Tissue-based Products

• Stem Cell

Biological Safety Testing Products & Services Test Outlook (Revenue, USD Million, 2021 - 2033)

• Endotoxin Tests

• Sterility Tests

• Cell Line Authentication & Characterization Tests

• Bioburden Tests

• Adventitious Agent Detection Tests

• Residual Host Contamination Detection Tests

• Others

Biological Safety Testing Products & Services Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Biological Safety Testing Products And Services Market

• Charles River Laboratories

• BSL Bioservice

• Merck KGaA (MilliporeSigma)

• Samsung Biologics

• Sartorius AG

• Eurofins Scientific

• SGS Société Générale de Surveillance SA

• Thermo Fisher Scientific Inc.

• BIOMÉRIEUX

• Lonza